Skip to content

Comparison of esketamine and sufentanil combined with propofol for sedation undergoing endoscopic ultrasound:A randomized, controlled study

Comparison of esketamine and sufentanil combined with propofol for sedation undergoing endoscopic ultrasound:A randomized, controlled study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090306
Enrollment
Unknown
Registered
2024-09-27
Start date
2023-12-20
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

digestive system disease

Interventions

esketamine group:Induction of anesthesia: Esketamine 0.25mg/kg was slowly injected intravenously, then propofol was given 1.5-2mg /kg.
sunfentanil group:Induction of anesthesia: Sufentanil 0.1µg/kg was slowly injected intravenously, then propofol was given 1.5-2mg /kg.

Sponsors

the Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1)patients undergoing EUS under sedation; 2)American Society of Anesthesiologists (ASA) grade I-?; 3)aged 18-75 years old; 4)Mallampati grade I-III.

Exclusion criteria

Exclusion criteria: 1)patients who may need to pump water into the esophagus and stomach in the examination process; 2)sleep apnea history; 3)evident difficult airway; 4)BMI>30; 5)Severe liver and kidney dysfunction; 6)patients who refused to participate.

Design outcomes

Primary

MeasureTime frame
Incidence of respiratory depression;

Secondary

MeasureTime frame
incidence of body movement;propofol induction dosage, supplemental times and total dosage;lowest SPO2;management of airway obstruction;

Countries

China

Contacts

Public ContactZangong Zhou

the Affiliated Hospital of Qingdao University

zhouzangong@qdu.edu.cn+86 186 6180 9873

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026